Hangzhou Tigermed Consulting Co., Ltd Share Price
Equities
300347
CNE100001KV8
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.58 CNY | +2.06% |
|
+6.47% | +5.42% |
Capitalization | 47.4B 6.6B 5.64B 5.26B 4.86B 9.05B 566B 10.11B 62.9B 23.93B 264B 24.76B 24.25B 967B | P/E ratio 2025 * |
45x | P/E ratio 2026 * | 34.4x |
---|---|---|---|---|---|
Enterprise value | 47.1B 6.56B 5.6B 5.22B 4.83B 8.99B 562B 10.05B 62.51B 23.78B 263B 24.61B 24.1B 961B | EV / Sales 2025 * |
6.63x | EV / Sales 2026 * | 5.81x |
Free-Float |
72.37% | Yield 2025 * |
0.52% | Yield 2026 * | 0.65% |
More valuation ratios
* Estimated data
More news
More recommendations
More press releases
1 day | +2.06% | ||
1 week | +6.47% | ||
Current month | +7.99% | ||
1 month | +15.09% | ||
3 months | +25.31% | ||
6 months | +14.02% | ||
Current year | +5.42% |
1 week | 52.7 | ![]() | 58.89 |
1 month | 48.17 | ![]() | 58.89 |
Current year | 41.61 | ![]() | 62.25 |
1 year | 41.61 | ![]() | 82.79 |
3 years | 36.12 | ![]() | 130 |
5 years | 36.12 | ![]() | 209.41 |
10 years | 14.2 | ![]() | 209.41 |
Manager | Title | Age | Since |
---|---|---|---|
Xiao Chun Cao
CEO | Chief Executive Officer | 56 | - |
Cheng Cheng Yang
DFI | Director of Finance/CFO | 51 | 20/10/2022 |
Hao Wu
PSD | President | 57 | 31/12/2019 |
Director | Title | Age | Since |
---|---|---|---|
Xiao Chun Cao
BRD | Director/Board Member | 56 | 31/12/2004 |
Xiao Ping Ye
CHM | Chairman | 62 | - |
Zhi Min Chen
BRD | Director/Board Member | 65 | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+2.06% | +6.47% | +17.51% | -51.98% | 6.44B | ||
+1.26% | +0.68% | +11.49% | -1.12% | 49.23B | ||
+4.32% | +4.21% | +76.16% | +43.83% | 28.96B | ||
-1.33% | -1.39% | -23.79% | -25.32% | 28.45B | ||
+0.34% | +9.79% | +4.85% | +9.59% | 28.26B | ||
+0.03% | -1.58% | +27.86% | -23.32% | 12.53B | ||
-0.59% | -0.02% | -53.46% | -29.73% | 12.05B | ||
+0.17% | -1.45% | +16.33% | -5.68% | 10.36B | ||
+5.03% | +1.93% | +29.31% | +94.38% | 10.18B | ||
-0.46% | -0.84% | +70.09% | - | 10.13B | ||
Average | +1.08% | +0.34% | +17.64% | +1.18% | 19.66B | |
Weighted average by Cap. | +1.08% | +0.04% | +16.42% | +3.65% |
2025 * | 2026 * | |
---|---|---|
Net sales | 7.1B 989M 845M 787M 728M 1.36B 84.77B 1.51B 9.42B 3.59B 39.61B 3.71B 3.63B 145B | 8.03B 1.12B 955M 890M 823M 1.53B 95.89B 1.71B 10.66B 4.05B 44.8B 4.2B 4.11B 164B |
Net income | 1.11B 155M 132M 123M 114M 212M 13.26B 237M 1.47B 561M 6.19B 580M 568M 22.66B | 1.54B 214M 183M 170M 158M 293M 18.34B 328M 2.04B 776M 8.57B 803M 786M 31.36B |
Net Debt | -298M -41.53M -35.48M -33.06M -30.58M -56.91M -3.56B -63.62M -396M -151M -1.66B -156M -153M -6.09B | -740M -103M -88.01M -82.02M -75.86M -141M -8.83B -158M -982M -374M -4.13B -386M -378M -15.1B |
More financial data
* Estimated data
Employees
10,185
Calendar
Date | Price | Change | Volume |
---|---|---|---|
08/07/25 | 57.58 ¥ | +2.06% | 17,837,990 |
08/07/25 | 56.42 ¥ | +6.47% | 19,641,070 |
07/07/25 | 52.99 ¥ | -1.43% | 5,953,595 |
04/07/25 | 53.76 ¥ | -0.67% | 8,535,043 |
03/07/25 | 54.12 ¥ | +0.59% | 9,059,009 |
End-of-day quote Shenzhen S.E., July 08, 2025
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
57.58CNY
Average target price
54.42CNY
Spread / Average Target
-5.49%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300347 Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition